The effect of the sildenafil citrate on cerebral vasospasm and apoptosis following experimental subarachnoid hemorrhage in rats

Journal of Neurosurgical Sciences

Volumn 54, Issue 1, 2010, Pages 29-37

  Gokce, C ^a   Gulsen, S ^a   Yilmaz, C ^a   Guven, G ^a   Caner, H ^a   Altinors, N ^a  

^a BASKENT UNIVERSITY   (Turkey)

Author keywords

Basilar artery; Sildenafil; Vasospasm, intracranial

Indexed keywords

SILDENAFIL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTERY DIAMETER; ARTICLE; BASILAR ARTERY; BRAIN TISSUE; BRAIN VASOSPASM; CONTROLLED STUDY; DRUG EFFECT; IMMUNOHISTOLOGY; LIPID PEROXIDATION; MALE; NONHUMAN; RAT; SUBARACHNOID HEMORRHAGE;

ANIMALS; APOPTOSIS; DISEASE MODELS, ANIMAL; IMMUNOHISTOCHEMISTRY; IN SITU NICK-END LABELING; LIPID PEROXIDATION; MALE; PIPERAZINES; PURINES; RATS; RATS, SPRAGUE-DAWLEY; SUBARACHNOID HEMORRHAGE; SULFONES; VASODILATOR AGENTS; VASOSPASM, INTRACRANIAL; VERTEBROBASILAR INSUFFICIENCY;

EID: 77954747208     PISSN: 00264881     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (64)

1. Haley EC Jr, Kassell NF, Alves WM, Weir BK, Hansen CA. Phase II trial of tirilazad in aneurysmal subarachnoid hemorrhage. A report of the CooperativeAneurysm Study. J Neurosurg 1995;82:786-90.
2. Kassell NF, Torner JC, Haley EC Jr, Jane JA, Adams HP, Kongable GL. The International Cooperative Study on the Timing of Aneurysm Surgery. Part 1: Overall management results. J Neurosurg 1990;73:18-36. (Pubitemid 20206379)
3. Fisher CM, Kistler JP, Davis JM. Relation of cerebral vasospasm to subarachnoid hemorrhage visualized by computerized tomographic scanning. Neurosurgery 1980;6:1-9.
4. Heros RC, Zervas NT, Varsos V. Cerebral vasospasm after subarachnoid hemorrhage: An update. Ann Neurol 1983;14:599-08. (Pubitemid 14211605)
5. Biller J, Godersky JC, Adams HP Jr. Management of aneurysmal subarachnoid hemorrhage. Stroke 1988;19:1300-5.
6. Hop JW, Rinkel GJ, Algra A, van Gijn J. Case- fatality rates and functional outcome after subarachnoid hemorrhage: A systematic review. Stroke 1997;28:660-4.
7. Barker FG, Ogilvy CS. Efficacy of prophylactic nimodipine for delayed ischemic deficit after subarachnoid hemorrhage: A metaanalysis. J Neurosurg 1996;84:405-14.
8. Rinkel GJ, Feigin VL, Algra A, van den Bergh WM, Vermeulen M, van Gijn J. Calcium antagonists for aneurysmal subarachnoid haemorrhage. Cochrane Database Syst Rev 2005;25:CD 000277.
9. Treggiari-Venzi MM, Suter PM, Romand JA. Review of medical prevention of vasospasm after aneurysmal subarachnoid hemorrhage: A problem of neurointensive care. Neurosurgery 2001;48:249-62.
10. Weyer GW, Nolan CP, Macdonald RL. Evidence- based cerebral vasospasm management. Neurosurg Focus 2006;21:E8.
11. Dumont AS, Dumont RJ, Chow MM, Lin CL, Calisaneller T, Ley KF, et al. Cerebral vasospasm after subarachnoid hemorrhage: putative role of inflammation. Neurosurgery 2003;53:123-35.
12. Hingorani AD, Cross J, Kharbanda RK, Mullen MJ, Bhagat K, Taylor M et al. Acute systemic inflammation impairs endothelium-dependent dilatation in humans. Circulation 2000;102:994-9.
13. Hino A, Tokuyama Y, Weir B, Takeda J, Yano H, Bell GI, et al. Changes in endothelial nitric oxide synthase mRNA during vasospasm after subarachnoid hemorrhage in monkeys. Neurosurgery 1996;39:562-8. (Pubitemid 26292030)
14. Hogg N, Darley-Usmar VM, Wilson MT, Moncada S. Production of hydroxyl radicals from the simultaneous generation of superoxide and nitric oxide. Biochem J 1992;281:419-24.
15. Kamii H, Kato I, Kinouchi H, Chan PH, Epstein CJ, Akabane A et al. Amelioration of vasospasm after subarachnoid hemorrhage in transgenic mice overexpressing CuZn-superoxide dismutase. Stroke 1999;30:867-72.
16. Kuo PC, Abe K, Schroeder RA. Superoxide enhances interleukin 1 beta-mediated transcription of the hepatocyte-inducible nitric oxide synthase gene. Gastroenterology 2000;118:608-18.
17. McGirt MJ, Parra A, Sheng H, Higuchi Y, Oury TD, Laskowitz DT et al. Attenuation of cerebral vasospasm after subarachnoid hemorrhage in mice overexpressing extracellular superoxide dismutase. Stroke 2002;33:2317-23.
18. Medele RJ, Stummer W, Reulen HJ, Steiger HJ. Evidence for peroxidative damage by nitric oxide in experimental chronic cerebral vasospasm. Neurol Res 1996;18:277-80.
19. Pluta RM. Delayed cerebral vasospasm and nitric oxide: review, new hypothesis, and proposed treatment. Pharmacol Ther 2005;105:23-56
20. Sayama T, Suzuki S, Fukui M. Role of inducible nitric oxide synthase in the cerebral vasospasm after subarachnoid hemorrhage in rats. Neurol Res 1999;21:293-8. (Pubitemid 29205451)
21. Sercombe R, Dinh YR, Gomis P. Cerebrovascular inflammation following Subarachnoid hemorrhage. Jpn J Pharmacol 2002;88:227-49.
22. Widenka DC, Medele RJ, Stummer W, Bise K, Steiger HJ. Inducible nitric oxide synthase: a possible key factor in the pathogenesis of chronic vasospasm after experimental subarachnoid hemorrhage. J Neurosurg 1999;90:1098-104. (Pubitemid 29241179)
23. Faraci FM, Sobey CG. Role of potassium channels in regulation of cerebral vascular tone. J Cereb Blood Flow Metab 1998;18:1047-63.
24. Sobey CG, Quan L. Impaired cerebral vasodilator responses to nitric oxide and PDE V inhibition after subarachnoid hemorrhage. Am J Physiol 1999;277:1718-24.
25. Calvert JW, Zhou C, Nanda A, Zhang JH. Effect of hyperbaric oxygen on apoptosis in neonatal hypoxia-ischemia rat model. J Appl Physiol 2003;95:2072-80. (Pubitemid 37310393)
26. Trandafir CC, Nishihashi T, Wang A, Murakami S, Ji X, Kurahashi K. Participation of vasopressin in the development of cerebral vasospasm in a rat model of subarachnoid haemorrhage. Clin Exp Pharmacol Physiol 2004;31:261-6.
27. Gavrieli Y, Sherman Y, Ben-Sasson SAJ. Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation. Cell Biol 1992;119:493-501.
28. Hsu SM, Raine L, Fanger H. The use of antiavidin antibody and avidin-biotin-peroxidase complex in immunoperoxidase technics. Am J Clin Pathol 1981;75:816-21. (Pubitemid 11063879)
29. Hsu SM, Raine L, Fanger H. Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures. J Histochem Cytochem 1981;29:577-80. (Pubitemid 11147380)
30. Mihara M, Uchiyama M. Determination of malonaldehyde precursor in tissues by thiobarbituric acid test. Anal Biochem 1978;86:271-8. (Pubitemid 9050395)
31. Beavo JA. Cyclic nucleotide phosphodiesterases: functional implications of multiple isoforms. Physiol Rev 1995;75:725-48.
32. Gilad R, Lampl Y, Eshel Sadeh M. Tonic-clonic seizures in patients taking sildenafil. BMJ 2002;325:869. (Pubitemid 35215259)
33. Gresser U, Gleiter CH. Erectile dysfunction: comparison of efficacy and side effects of the PDE-5 inhibitors sildenafil, vardenafil and tadalafil: review of the literature. Eur J Med Res 2002;7:435-46.
34. Senzaki H, Smith CJ, Juang GJ, Isoda T, Mayer SP, Ohler A et al. Cardiac phosphodiesterase 5 (cGMP-specific) modulates -adrenergic signaling in vivo and is downregulated in heart failure. FASEB J 2001;15:1718-26.
35. Inoha S, Inamura T, Ikezaki K, Nakamizo A, Amano T, Fukui M. Type V phosphodiesterase expression in cerebral arteries with vasospasm after subarachnoid hemorrhage in a canine model. Neurol Res 2002;24:607-12.
36. Tessler R, Wu S, Fiori R, Macgowan CK, Belik J. Sildenafil acutely reverses the hypoxic pulmonary vasoconstriction response of the newborn pig. Pediatr Res 2008;64:251-5.
37. Muzaffar S, Jeremy JY, Sparatore A, Del Soldato P, Angelini GD, Shukla N. H2S-donating sildenafil (ACS6) inhibits superoxide formation and gp91phox expression in arterial endothelial cells: role of protein kinases A and G. Br J Pharmacol 2008;155:984-94.
38. Cook DA. Mechanisms of cerebral vasospasm in subarachnoid haemorrhage. Pharmacol Ther 1995;66:259-84.
39. Kim P, Schini VB, Sundt TM, Vanhoutte PM. Reduced production of cGMP underlies the loss of endothelium-dependent relaxations in the canine basilar artery after subarachnoid hemorrhage. Circ Res 1992;70:248-56.
40. Weir B. The pathophysiology of cerebral vasospasm. Br J Neurosurg 1995;9:375-90.
41. Quan L, Sobey CG. Selective effects of subarachnoid hemorrhage on cerebral vascular responses to 4-aminopyridine in rats. Stroke 2000;31:2460-5.
42. Sobey CG, Faraci FM. Inhibitory effect of 4-aminopyridine on responses of the basilar artery to nitric oxide. Br J Pharmacol 1999;126:1437-43.
43. Nijhawan D, Honarpour N, Wang X. Apoptosis in neural developmentand disease. Annu Rev Neurosci 2000;23:73-87.
44. Onoue H, Katusic ZS. Role of potassium channels in relaxations of canine middle cerebral arteries induced by nitric oxide donors. Stroke 1997;28:1264-71. (Pubitemid 27248905)
45. Sampson LJ, Hinton JM, Garland CJ. Evidence for expression and function of phosphodiesterase type 5 (PDE-V) in rat resistance arteries. Br J Pharmacol 2001;132:13-7.
46. Sobey CG, Faraci FM. Subarachnoid haemorrhage: What happens to the cerebral arteries? Clin Exp Pharmacol Physiol 1998;25:867-76.
47. Meguro T, Chen B, Lancon J, Zhang JH. Oxyhemoglobin induces caspasemediated cell death in cerebral endothelial cells. J Neurochem 2001;77:1128-35.
48. Ogihara K, Zubkov AY, Parent AD, Zhang JH. Oxyhemoglobin produces necrosis in cultured smooth muscle cells. Acta Neurochir Suppl 2000;76:507-10.
49. Pluta RM, Oldfield EH, Boock RJ. Reversal and prevention of cerebral vasospasm by intracarotid infusions of nitric oxide donors in a primate model of subarachnoid hemorrhage. J Neurosurg 1997;87:746-51.
50. Zhou C, Yamaguchi M, Kusaka G, Schonholz C Nanda A. Caspase inhibitors prevent endothelial apoptosis cerebral vasospasm in dog model of experimental subarachnoid hemorrhage. J Cereb Blood Flow Metab 2004;24:419-31. (Pubitemid 38452233)
51. Zhou C, Yamaguchi M, Colohan A, Zhang JH. Role of apoptosis in cerebral vasospasm after experimental subarachnoid hemorrhage. J. Cereb. Blood Flow Metab. 2005;25:572-82.
52. Chen G, Zhang S, Shi J, Ai J, Hang C. Effects of recombinant human erythropoietin (rhEPO) on JAK2/STAT3 pathway and endothelial apoptosis in the rabbit basilar artery after subarachnoid hemorrhage. Cytokine 2009;45:162-8.
53. Cheng G, Wei L, Zhi-Dan S, Shi-Guang Z, Xiang-Zhen L. Atorvastatin ameliorates cerebral vasospasm and early brain injury after subarachnoid hemorrhage and inhibits caspase-dependent apoptosis pathway. BMC Neurosci 2009;21:10:7.
54. Gao C, Liu X, Liu W, Shi H, Zhao Z, Chen H, et al. Anti-apoptotic and neuroprotective effects of Tetramethylpyrazine following subarachnoid hemorrhage in rats. Auton Neurosci 2008;141:22-30.
55. O'Brate A, Giannakakou P. The importance of p53 location: nuclear or cytoplasmic zip code? Drug Resist Updat 2003;6:313-22.
56. Antonsson B, Martinou JC. The Bcl-2 protein family. Exp Cell Res 2000;256:50-7.
57. Cregan SP, Fortin A, MacLaurin JG, Callaghan SM, Cecconi F, Yu SW et al. Apoptosis inducing factor is involved in the regulation of caspase-independent neuronal cell death. J Cell Biol 2002;158:507-17.
58. Cahill J, Calvert JW, Marcantonio S, Zhang JH. p53 may play an orchestrating role in apoptotic cell death after experimental subarachnoid hemorrhage. Neurosurgery 2007;60:531-45.
59. Matz PG, Fujimura M, Lewen A, Morita-Fujimura Y, Chan PH. Increased cytochrome c-mediated DNA fragmentation and cell death in manganese-superoxide dismutase-deficient mice after exposure to subarachnoid hemolysate. Stroke 2001;32:506-15. (Pubitemid 32155243)
60. Matz PG, Copin JC, Chan PH. Cell death after exposure to subarachnoid hemolysate correlates inversely with expression of CuZn-superoxide dismutase. Stroke 2000;31:2450-9.
61. Matz PG, Fujimura M, Chan PH. Subarachnoid hemolysate produces DNA fragmentation in a pattern similar to apoptosis in mouse brain. Brain Res 2000;858:312-9.
62. Santhanam AV, Smith LA, Nath KA, Katusic ZS. In vivo stimulatory effect of erythropoietin on endothelial nitric oxide synthase in cerebral arteries. Am J Physiol Heart Circ Physiol 2006:291:781-6.
63. Koupparis AJ, Jeremy JY, Muzaffar S, Persad R, Shukla N. Sildenafil inhibits the formation of superoxide and the expression of gp47 NADPH oxidase induced by the thromboxane A2 mimetic, U46619, in corpus cavernosal smooth muscle cells. BJU Int 2005;96:423-7.
64. Atalay B, Caner H, Cekinmez M, Ozen O, Celasun B, Altinors N. Systemic administration of phosphodiesterase V inhibitor, sildenafil citrate, for attenuation of cerebral vasospasm after experimental subarachnoid hemorrhage. Neurosurgery 2006 59:1102-8.